TAM
OLMA icon

Titleist Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Titleist Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$147K – 391
2025
Q3 		$147K Hold
15,000
– – 0.01% 311
2025
Q2 		$63.9K Buy
+15,000
New +$66.9K 0.01% 316

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Titleist Asset Management's OLMA Position: Q4 2025 in Review

Titleist Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q4 2025, closing a stake of 15,000 shares — an estimated $147K sold.

Titleist Asset Management first reported a position in OLMA in Q2 2025 and held it in 2 quarters. The position peaked at $147K in Q3 2025. 200 funds tracked by Wall St. Rank hold OLMA as of Q4 2025.

  • Titleist Asset Management reported no remaining Olema Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Titleist Asset Management sold 15,000 Olema Pharmaceuticals shares in Q4 2025, an estimated $147K.
  • Titleist Asset Management first reported a position in Olema Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Titleist Asset Management's Olema Pharmaceuticals position peaked at $147K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2025.

Based on Titleist Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.